Tagcloud

abortion, abuse, acute care, addiction, administration, alcohol, alternative medicine, arthritis, autoimmune disorders, blood, breast cancer, Brendan Drumm, cancer, capacity, cardiovascular disease, casemix, CervicalCheck, charity, children, clinical directors, co-location, community care, competence assurance, Competition Authority, complaints, consultants, cosmetic surgery, costs, cross-border, cutbacks, cystic fibrosis, Department of Health, diabetes, disability, Down's syndrome, drugs, e-health, education, elderly, emergency medicine, epilepsy, equity, ESRI, EWTD, fertility, Fitness to Practice, fractures, funding, General Election, genetics, GPs, Hanly report, HIQA, HIV, HPSC, HRB, hse, HSE, human tissue, hygiene, hypertension, IBTS, ICGP, IHCA, IMB, immunity, IMO, imo, industrial action, influenza, INO, insurance, Irish Healthcare Awards, IT, locums, LRC, lung disease, maternity, MAUs, media, medical cards, Medical Council, medical school, medico-legal, men's health, mental health, migraine, MRSA, NCHDs, needle-stick injury, neurology, NHS, Non-EU doctors, North East, NTPF, nurses, nursing home, nutrition, obesity, obstetrics, Ombudsman, out-of-hours, palliative care, pandemic, patient records, PCRS (GMS), pharmaceuticals, pharmacy, politics, practice management, pregnancy, prescribing, primary care, privatisation, quality, radiology, radiotherapy, RCPI, RCSI, reconfiguration, recruitment, regional hospitals, renal, research, savings, screening, sexual assault, sexual health, smoking, sports medicine, stem cells, stroke, suicide, surgery, transplants, transport, tuberculosis, vaccine, Vhi, waiting lists, WHO, women's health, work-life balance

«Previous article

Soy product withdrawn over thyroid risk

The Health Protection Surveillance Centre (HPSC) has issued advice to doctors following the withdrawal of a soy milk product from the Irish market by the Food Safety Authority of Ireland (FSAI).

BonSoy has been withdrawn following the detection that it contained high levels of iodine. Doctors are advised to ask patients presenting with thyroid conditions about their consumption of BonSoy.

Up to eight adults in one practice in New South Wales in Australia have been diagnosed with thyroid conditions believed to be associated with the product. A newborn in Australia has also been diagnosed with hypothyroidism, after the mother drank BonSoy during pregnancy.

Adults who drink 30mls per day and children who drink 5mls a day are at risk of exceeding the safe upper limit for iodine intake.

The product is made in Japan and distributed in Australia, Ireland and many other countries. All products produced from January 1, 2009 have been withdrawn.
For more information on medical management see www.hpsc.ie.

Posted in Public Health on 18 January 2010
Tags: